CHILTON INVESTMENT CO INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.

Quarter-by-quarter ownership
CHILTON INVESTMENT CO INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2017$1,324,000
-83.0%
120,000
+120.1%
0.05%
-80.9%
Q4 2014$7,801,000
+9.1%
54,5090.0%0.27%
+13.3%
Q3 2014$7,152,000
+427.8%
54,509
+407.3%
0.24%
+336.4%
Q2 2014$1,355,000
-57.2%
10,745
-55.2%
0.06%
-43.9%
Q1 2014$3,165,000
+12.3%
24,0100.0%0.10%
+19.5%
Q4 2013$2,819,00024,0100.08%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders